Most Popular

J.M. Smucker Emerges as a Leading SAFE Dividend Stock Offering 4.3% Yield

J.M. Smucker Co. (SJM) has been included in the Dividend Channel’s “S.A.F.E. 25” list, indicating a strong dividend profile with a yield of 4.3%. ...

TTMI Surpasses Average Analyst Price Target

TTM Technologies Inc (TTMI) shares recently traded at $35.65, surpassing the average analyst 12-month target price of $35.00. This movement comes amid a backdrop ...

GWW Surpasses Average Analyst Expectations

W.W. Grainger Inc. (GWW) shares recently surpassed the average analyst 12-month target price of $486.00, trading at $495.00 per share. This shift prompts analysts ...

KSS Surpasses Average Analyst Predictions

Kohl’s Corp. (NYSE: KSS) shares recently traded above the average analyst 12-month target price of $31.00, reaching $31.23 per share. This movement signals potential ...

WRBY Surpasses Average Analyst Price Target

Shares of Warby Parker Inc (Ticker: WRBY) recently traded at $29.09, surpassing the average 12-month analyst target price of $26.92. This significant movement raises ...

AEIS Surpasses Average Analyst Price Target

Advanced Energy Industries Inc (AEIS) shares recently surpassed the average analyst 12-month target price of $103.71, trading at $106.85 per share. Analysts are now ...

Gurit Holding (SWX:GURN) Reduces Price Target by 40.91% to 13.26

The average one-year price target for Gurit Holding (SWX:GURN) has been revised to CHF 13.26 per share, marking a significant decrease of 40.91% from ...

Top Strong Buy Stocks to Consider for January 14th

Five stocks have been added to the Zacks Rank #1 (Strong Buy) List today. These include: Brainsway (BWAY): This medical device company reported a ...

U.S. Gold (USAU) Price Target Rises 11.80% to 24.15

The average one-year price target for U.S. Gold (NasdaqCM:USAU) has been revised to $24.15 per share, marking an increase of 11.80% from the previous ...

Greenwich LifeSciences (GLSI) Sees 13.10% Boost in Price Target to 48.45

The average one-year price target for Greenwich LifeSciences (NasdaqCM:GLSI) has been raised to $48.45 per share, representing a 13.10% increase from the previous estimate ...